Cargando…
PET/MR and PET/CT in a severe COVID-19 patient
Autores principales: | Li, Xiaochen, Wang, Yan, Bai, Yan, Xu, Junling, Fu, Chang, Kang, Yi, Cheng, Jianjian, Shen, Yu, Liu, Junping, Wu, Hewen, Zhang, Weifeng, Li, Huiqiang, Li, Pengyu, Gu, Jianqin, Shao, Fengmin, Wang, Meiyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272209/ https://www.ncbi.nlm.nih.gov/pubmed/32500167 http://dx.doi.org/10.1007/s00259-020-04887-8 |
Ejemplares similares
-
FDG PET/CT evaluation of a patient recovering from COVID-19
por: Fu, Chang, et al.
Publicado: (2020) -
Relapsing polychondritis detected in PET/CT
por: Czepczyński, Rafał, et al.
Publicado: (2012) -
Active inflammation in (18)F-methylcholine PET/CT
por: Le, Chau, et al.
Publicado: (2009) -
Zirconium-89 labelled rituximab PET-CT imaging of Graves’ orbitopathy
por: de Keizer, Bart, et al.
Publicado: (2019) -
Cylindroma, an uncommon presentation on (18)F-DCFPyL PET/CT
por: Koene, B. P. F., et al.
Publicado: (2020)